Medicament dry powder inhaler dispensing device

Information

  • Patent Grant
  • 6752148
  • Patent Number
    6,752,148
  • Date Filed
    Friday, September 1, 2000
    24 years ago
  • Date Issued
    Tuesday, June 22, 2004
    20 years ago
Abstract
An inhaler disc cartridge comprises a carrier disc with radially outwardly extending resilient fingers, each with a medicament powder dosage. A sealing disc and an indexing ring are bonded to the disc. A cam sequentially and manually deflects a selected finger causing it to snap against an anvil to release the dosage by momentum energy transfer. In other embodiments, a cassette includes a carrier substrate reel of deposited powder dosages with a dosage sealing tape. The substrate comprises a belt with a plurality of transversely extending triangular fingers, each finger tip with a dosage thereon. Each finger is snapped in sequence against an anvil while a clamp secures the belt as the fingers are deflected. The spring fingers are corrugated in one embodiment cooperating with an anvil having channels and a device for inducing agglomeration breakup air streams through the channels. Other embodiments are for impact deflection of a dosage carrying substrate in a cartridge or cassette against an anvil to release the dosages.
Description




This invention relates to inhalers for medicaments, and more particularly, to inhalers with arrangements for breaking up agglomerates of dry powder.




In addition, of interest are PCT applications WO 90/13328 and WO 93/09832. These latter applications disclose various inhaler embodiments including impact release of medicament dosages. However, these embodiments involve relatively complex camming and similar arrangements which are costly to implement. These latter applications are also incorporated by reference herein.




Dry powder inhalers are used as drug delivery devices for administering pharmaceutical compounds to individuals. Some of these devices employ a pharmaceutical powder deposited on a substrate surface and sealed with a sealing layer. In other devices, the powder may be supplied in a reservoir and then transferred to a dose carrier one dose at a time. The substrate may be provided as a tape on a reel in cassettes or in cartridges, for example. When the patient requires medication, the ideal dry powder inhaler forms a fine particle cloud that is to be inhaled and thereby delivers a high respirable fraction of the stored dose deeply into the patients lungs. In most cases, the deep recesses of the lung is the desired site for the drugs in the inhaled powder cloud.




This can be most efficiently achieved by:




1. Releasing a high fraction of the deposited drug and




2. Insuring that the powder cloud consists of individual particles or particle aggregates between 1 μm and 5 μm.




As individual particles are reduced below 10 μm, both release and particle aggregation become a serious hindrance to delivering a high respirable fraction deeply into the patient's lungs.




A common problem addressed by various prior art inhaler apparatuses for dispensing dry powder medicaments is providing for a controlled reliable release of the medicament. The dry powder medicaments inhalers may be loaded with medicaments by filling techniques not involving electrostatics. In certain other implementations, the deposited powder tends to form agglomerated particles resulting in uncontrolled variation in the amount of medicament released. Several of the aforementioned applications provide various solutions to this problem.




Numerous approaches have been taken in the design of dry powder inhalers. In some cases, the powder is released by impact of a substrate powder carrier, as disclosed in WO 93/09832. Of interest is an inhaler as disclosed in WO 90/13328.




In copending applications Ser. Nos. 661,213 and 661,212, indentations or raised surfaces are disclosed in the inhaler interior surfaces having contact with the medicament for inhalation, the surfaces minimizing the area of contact between the medicament and the surfaces of the inhaler apparatus, promoting the release of the medicament from the inhaler.




When particles of medicament agglomerate, they impact the mouth and throat rather than remain in the air flow for deposition in the lungs. One remedy is to provide tortuous channels in the inhalers to promote deagglomeration. However, the medicament may be deposited along the channels leading to inaccurate dosage dispensing. Agglomeration also results in the inhaler tending to dispense the medicament inaccurately so that greater or lesser amounts are dispensed.




The small particle size, e.g., 2 μm to 7 μm, required for transport to the lung presents a number of problems for release by the inhaler and delivery to deep lung regions. As the particle size decreases, the relative bonding force between the particle and other objects increases. This applies to both particle-to-substrate bonding and particle-to-particle bonding. As a result, particle aggregates become more tightly bound and individual particles more difficult to remove from the substrate. Aggregation increases the effective size of the drug released and diminishes the respirable fraction. The increase in relative particle-to-substrate bonding makes drug release more difficult and also decreases the respirable fraction.




Additional investigation using ultrasonic frequencies to agitate the surfaces have been unsuccessful in removing particles below 10 μm from a planar surface. There is a mismatch between the particle size and the wavelength of the substrate material in typical polymeric materials. The wavelengths of the material are a large multiple of the dimensions of the particles and does not provide efficient energy coupling. Acoustic frequencies above 100 MHz would be required for particle resonance to occur. Thus, either unrealistically high frequencies to minimize wavelength or high acoustic amplitudes to increase the force differential across the small particles are required.




The present inventors recognize a need for a drug inhaler delivery system for dry powder pharmaceutically active ingredients for breaking up such particle aggregation should they form. They recognize a need for delivery of microgram depositions in quantities ranging from about 10 μg to the milligram range with a delivery accuracy of about 10%.




A medicament powder delivery device according to the present invention comprises a carrier having at least a flexible portion on which portion is deposited a discrete medicament dosage and means for imparting an energy pulse to the carrier flexible portion for deflecting the carrier portion and releasing the dosage from the deflected portion by momentum transfer.




In one aspect, the means for imparting an energy pulse comprises means for flexing and snap releasing the flexed carrier portion.




In a further aspect, the carrier portion includes a finger resiliently extending from a carrier base region, the means for imparting for flexing the finger relative to the base region.




In a further aspect, a body is included with a cavity for receiving the carrier portion and the means for imparting including an anvil with a bore therethrough fixed to the body in the cavity for receiving the snap released finger, the bore for receiving the released dosage, and including means for causing the finger to resiliently impact the anvil to rapidly decelerate the finger to provide the momentum transfer to the dosage.




In a further aspect, the dosage tends to form aggregates, the anvil including at least one channel, further including means coupled to the housing for creating an air jet stream through the at least one channel to disintegrate aggregations of the dosage during the impact.




In a further aspect, the finger is corrugated.




In a still further aspect, the finger extends in a given direction from the base region, the finger having corrugations extending along the given direction.




The means for creating the jet stream may include a further resilient finger overlying the carrier finger for initial resilient displacement coincident with initial displacement of the carrier finger, the displaced fingers for snap release in a second displacement, the further finger for creating the air stream during the second displacement.




In a further aspect, the further finger has a different spring constant than the carrier finger so as to accelerate slower than the carrier finger upon the snap release.




In a still further aspect, the carrier includes a first disc with a plurality of radially extending fingers, a dosage on each finger, and the means for imparting comprises cam means for snap flexing a selected finger to release the dosage on the selected finger.




Index means are preferably included for indexing the selected finger to a medicament release position for snap flexing the selected finger by the cam means.




The first disc may include a carrier disc with a plurality of first fingers each carrying a dosage, a spacer disc overlying the carrier disc with a plurality of second fingers overlying and corresponding to the first fingers and a ring with index holes and a third plurality of fingers over lying and corresponding to the first and second fingers, the spacer disc being bonded to the carrier and ring discs, the indexing means for selectively engaging the ring index holes.




Cam means are preferably provided for manually flexing the selected fingers.




The cam means may flex the first and second fingers past the third fingers.




In a further aspect, the carrier comprises a belt portion with a plurality of fingers extending transversely from the belt portion, each of the fingers having a separate dosage and arranged for selective resilient displacement relative to the belt portion.




In a still further aspect, drive means are included for displacing the belt to increment the fingers sequentially to a dosage release position.




The means for imparting may include a clamp for clamping the belt portion adjacent to a given finger and a deflecting member for selectively flexing and snap releasing the selected given flexed finger relative to the belt portion.




The carrier may comprise an element, the dosage comprising a plurality of discrete dosages in spaced relation on the element, the means for imparting including a carrier deflection member adjacent to the element, and means for momentarily bending and deflecting the element to momentum transfer release a selected dosage from the element upon release of the deflected element.




In a further aspect, means are included for selectively aligning successive dosages on the element to the deflection member.




In a further aspect, a core member is included and rotatable about an axis, the element comprising an array of fingers radially extending from the core member about the core member in a spiral about the axis, means selectively align and deflect each the finger to snap release a selected dosage from the selected finger by momentum transfer.




In a further aspect, the carrier comprises a spring finger for receiving a dosage and dosage substrate from a plurality of dosages and dosage substrates in a stack aligned one over another, and means are included for selectively placing successive dosages and dosage substrates on the carrier, the means for imparting including means for snap deflecting said finger against an anvil.











IN THE DRAWING





FIG. 1

is a side elevation sectional view of an inhaler according to one embodiment of the present invention with the inhaler housing open for receiving a pharmaceutical powdered dosage carrying substrate cartridge with the cartridge installed;





FIG. 2

is a plan sectional view of the inhaler of the embodiment of

FIG. 1

;





FIG. 3

is a plan exploded view of the substrate cartridge for the embodiment of

FIG. 1

;





FIG. 3



a


is a fragmented sectional side elevation view of the assembled substrate cartridge of

FIG. 3

;





FIG. 3



b


is a fragmented sectional side elevation view of an alternate embodiment for the cartridge of

FIG. 3



a;







FIG. 4

is a side elevation view of a cam and lever employed in the embodiments of

FIG. 1

;





FIGS. 5-7

are side elevation sectional views of the inhaler of

FIG. 1

showing various stages of release of the deposited dry powder medicament;





FIG. 8

is a diagrammatic side elevation view of a second embodiment of an inhaler apparatus without the housing or operating mechanism illustrating the medicament carrying substrate and dosage thereon;





FIG. 9

is a plan view of a portion of the substrate of

FIG. 14

;





FIG. 10

is a schematic diagram of an actuator for use in deflecting the fingers in the embodiment of

FIGS. 8 and 9

;





FIG. 11

is diagrammatic perspective view in more detail of a dry powder substrate for use in different embodiments herein;





FIG. 12

is an isometric fragmented view of a further substrate embodiment according to the present invention for use with the substrate embodiment of

FIG. 11

;





FIG. 13

is a side elevation fragmented sectional view of a further embodiment of a substrate and medicament for use in the embodiment of

FIGS. 11 and 12

;





FIG. 14

is a diagrammatic isometric view of a cassette embodiment for use in an impact inhaler;





FIG. 14



a


is a side elevation sectional view of the substrate for use in the embodiment of

FIG. 14

;





FIG. 15

is a diagrammatic isometric view of a second cassette embodiment for use in an impact inhaler;





FIG. 15



a


is a side elevation sectional view of a portion of the substrate and the anvil used in the embodiment of

FIG. 15

;





FIG. 15



b


is a side elevation view similar to that of

FIG. 15



a


but after the substrate is impacted;





FIG. 16

is a diagrammatic isometric view of a spiral embodiment of an impact inhaler medicament dosage delivery system;





FIG. 17

is a diagrammatic isometric view of a second embodiment of a spiral impact inhaler medicament dosage delivery system;





FIG. 18

is an isometric diagrammatic view of a further embodiment of an impact inhaler medicament dosage delivery system employing stacked dosage packs;





FIG. 18



a


is a side sectional elevation view of the stack of packs employed in the

FIG. 18

embodiment;





FIG. 19

is an isometric diagrammatic view of a second embodiment of an impact inhaler medicament dosage delivery system employing stacked substrates and medicament dosages; and





FIG. 19



a


is a side sectional elevation view of the each substrate of the stack of dosage packs employed in the

FIG. 19

embodiment.











Dry powder medicament particles forming unit dosages may be charged with a given polarity in a conventional charging mechanism such as tribo-electric chargers, induction charging and so on. The particles are deposited in controlled amounts on a substrate wherein the amount of active pharmaceutical ingredients deposited at each of a plurality of locations on the substrate does not vary from a predetermined amount by more than about 5%, for example.




Reference is made to application Ser. No. 09/095,246 entitled Dry Powder Deposition Process filed Jun. 10, 1998 in the name of Poliniak et al., now U.S. Pat. No. 6,063,194, and Ser. No. 09/095,616 entitled Pharmaceutical Product and Method of Making filed Jun. 10, 1998 in the name of Chrai et al., now U.S. Pat No. 6,303,143, noted in the introductory portion and incorporated by reference herein in their entirety. These applications disclose apparatus and processes for electrostatically depositing pharmaceutically active ingredient medicaments on a substrate including charging a dry powder medicament and electrostatically attracting the charged powder particles to a substrate. In particular, the medicament is deposited in controlled amounts at discrete locations on the substrate wherein the amounts deposited do not vary from a predetermined amount by more than 5%, for example. This process is preferred.




However, other processes for electrostatically depositing dry powder medicaments on a substrate are also disclosed in the aforementioned copending applications and patents noted in the introductory portion, all of which are incorporated by reference herein. Those processes disclose electrostatically depositing controlled amounts of dry powder medicaments on a substrate at discrete locations on the substrate. Variations of the disclosed processes herein may be employed to adapt those processes to a metal or non-metallic substrate. The substrate may be a tape, a strip or disk, for example, among other shaped substrates with or without resilient fingers. Medicaments are deposited on the fingers as will be described below as employed in certain of the present embodiments. Such depositions of dry powder particles on the various substrates as described hereinbelow are within the skill of those of ordinary skill in this art.




Particle removal from surfaces tends to be more difficult as particle size decreases. This is roughly a consequence of the adhesion force decreasing more slowly than the volume and surface area as a particle's size decreases. Since the volume and surface are generally related to removing forces and deaggregation, these forces become increasingly difficult to overcome as the particle size decreases.




Forces of adhesion and agglomeration caused by van der Waal's force increase as the area of contact between a particle and substrate or between two particles increase.




To obtain high respirable fractions, electrostatic deposition is preferred to minimize particle-substrate and particle-particle contact which minimizes adhesive and agglomeration forces respectively. Also, similarly charged particles will repel one another to further minimize agglomeration.




The substrates in the inhalers described below may be either metal, e.g., stainless steel, or non-metallic as known in this art and may be of any material suitable as a medicament substrate. Non-metallic substrates are selected to have the desired mechanical flexure properties in certain of the described embodiments, for use in the disclosed impact arrangements. The selection of a substrate material depends upon a given implementation as discussed later herein in connection with the various embodiments.




To effectively form a powder cloud for inhalation, the rudimentary particle must generally be below about 6 μm and large agglomerates disrupted if they form. For low dosages, sufficiently sparse drug layers can be deposited such that particle-particle interaction is minimal or the agglomerates that form are sufficiently small to reach the targeted region of the respiratory track.




For higher dosages of drugs, aggregates will form on the substrate. These aggregates can be disrupted by the application of energy during the process of dislodging the drug and/or through the exposure of the released aggregates to a sufficiently high gas velocity. The gas exerts a differential force across the aggregates due to differences in aerodynamic drag. These differences can arise due to either a gradient in the gas velocity or geometrical differences across the aggregate.




In

FIG. 1

, inhaler apparatus


60


includes a housing


62


defining a chamber


54


and a dispensing chamber


54


′. A battery


64


, a motor


66


energized selectively by the battery through a switch not shown, and a fan belt


68


driven about axis


69


by the motor


66


are located within the chamber


54


. A manually operated lever


70


with a cam


71


is rotatably secured to the housing


62


. The lever


70


and cam


71


pass through the chamber dispensing


54


′. Lever


70


rotates about axis


73


(

FIG. 7

) and passes through the chamber


54


. The lever has a manually operated knob


70


′, FIG.


2


. The cam


71


is integral and one piece with the lever


70


which may be molded thermoplastic. The cam


71


is located within the chamber


54


.




In

FIG. 4

, the cam


71


has a slot


56


and an ingress opening


58


. Opening


58


comprises two surfaces


59


and


59


′ spaced at 90° and symmetrical relative to the plane of the slot


56


. Opening


58


has its normal quiescent position as shown in

FIG. 1

with the slot horizontal and the surfaces


59


and


59


′ each 45° to the horizontal.




The housing


62


,

FIG. 1

, is preferably a clam shell comprising two halves


62


′ and


62


″ hinged at one end with a preferably living hinge and is molded one piece thermoplastic. The housing includes an integral one piece molded mouthpiece


72


attached to lower half


62


″. The mouthpiece


72


has an exit port


74


in fluid communication with the dispensing chamber


54


′ through opening


55


. A support


76


is in the dispensing chamber


54


′. A manually operated indexing device


78


is at the housing front. The indexing device


78


includes a knob


80


external chamber


54


′ and an index wheel


82


in the chamber


54


′ adjacent to the support


76


. The index wheel


82


is rotatably secured to the housing


62


half


62


″ and includes an annular array of angularly spaced indexing pins


84


. An optional thermoplastic member


86


is cantilevered from the support


76


in the drug dispensing chamber


54


′,

FIGS. 1 and 2

. The member


86


may be flat or arcuate. If flat it is resilient. If arcuate it may be rigid and curves downwardly as shown, FIG.


5


. The member


86


may be made of other materials if desired.




The mouthpiece


72


has a dispensing chamber


88


in fluid communication with the chamber


54


′ through the opening


55


. The chamber


88


is fluid coupled through a channel


90


to air inlet port


92


. Air flow actuated butterfly valves


94


are in channel


90


and chamber


88


. The housing includes a spindle


96


for receiving a drug delivery disc substrate assembly


98


. The received disc


98


is rotated about the spindle


96


by the indexing device


78


.




The substrate disc assembly


98


,

FIGS. 3 and 3



a


, forms a dosage cartridge. Assembly


98


comprises a multilayer circular disc including a spring metal, for example, leaf spring, dosage carrying disc


100


. The disc


100


has an annular array of radially outwardly extending leaf spring fingers


102


which are resilient in a direction normal to the plane of the disc


100


. A medicament dosage


104


as described previously hereinabove is deposited as described on a broad surface of each of the dosage carrier fingers


102


at their extended end region. The disc


100


has a central opening


106


for receiving the spindle


96


,

FIGS. 1 and 2

.




Overlying the disc


100


is a spacer (or sealing layer) disc


108


. Disc


108


serves to separate the substrate disc


100


from overlying sealing ring


114


. In the alternative, the disc


108


may also serve as a sealing layer. Disc


108


may be spring metal or thermoplastic and has holes


110


in this embodiment for receiving therein the respective dosages


104


on the disc


100


.




In the sealing layer embodiment, the substrate disc


100


has pockets each for receiving a corresponding discrete dosage. The disc


108


is planar and overlies the disc


100


. This is shown, for example in

FIG. 3



b


. In

FIG. 3



b


, disc


100


′ comprises spring fingers


102


′ each having a dosage receiving dimple or pocket


103


′. A separate discrete medicament dosage


104


′ is in the pocket


103


′. The sealing disc


108


′ has openings


110


at the pocket


103


′ for spacing the dosage


104


′ from the ring


114


′ finger


118


′. The disc


108


′ seals the dosage and is generally planar. When the disc


108


′ is removed from the disc


100


′ to release the dosage, the dosage


104


′ remains in place in the pocket


103


rather than possibly removed with the sealing disc


108


′ spaced from the dosage.




Disc


108


,

FIG. 3

, also has a central opening and fingers


112


corresponding to and overlying the respective opening


106


and fingers


102


of disc


100


. Disc


108


bonds the disc


100


thereto employing a conventional bonding agent for this purpose.




An indexing and sealing ring


114


overlies the disc


108


annular peripheral region. Ring


114


has a larger diameter than discs


100


and


108


so that an annular portion


116


extends radially outwardly of the underlying juxtaposed fingers


102


and


112


of the respective discs


100


and


108


. A plurality of radially inwardly extending fingers


118


overly the outer peripheral ends of the underlying fingers


102


and


112


of respective discs


100


and


108


. A circular array of disc indexing apertures


120


are in the ring


114


radially outwardly of the fingers


118


. The apertures


120


selectively engage the indexing pins


84


of the indexing device


78


,

FIG. 1

, one at a time.




The discs


100


,


108


and the fingers


118


of ring


114


are bonded together in a laminated structure by a conventional adhesive bonding agent forming the cartridge disc assembly


98


.




Means are provided for selectively placing and aligning successive dosages on an element to a deflection member, for example, such as by using indexing device


78


,

FIG. 1

, indexing pins


84


which selectively engage apertures


120


of ring


114


in the received disc assembly


98


by manual rotation of the knob


80


. The pins


84


place an overlying set of fingers


102


,


112


and


118


of the assembly


98


aligned with and overlying the member


86


. The ring


114


peripheral region


116


with the holes


120


are over the support


76


and member


86


. The spindle


96


receives the disc assembly


98


at opening


106


.




In operation, apparatus


60


provides a drug removal method that imparts an energy pulse for momentum transfer to the deposited powder through an impact mechanism for both low and high dosages. The disc assembly


98


is placed in operative position,

FIG. 1

, and the housing


62


chamber


54


is then closed, FIG.


5


. In this position, the cam


71


surfaces


59


and


59


′ are each 45° to the plane of the assembly


98


which passes through the slot


56


. When a switch, not shown, is activated, the motor


66


operates the fan


68


. This starts an air flow through the channel


90


via input port


92


and exits port


74


opening the butterfly valves


94


.




The extended tips of the fingers


102


and


112


may overlie the support


76


and also overlie the member


86


therebelow. The ring


114


is lowermost with the dosage facing downwardly toward the opening


55


. In this orientation, the other fingers


112


and


102


are over the ring fingers


118


with the dosage finger


102


uppermost. Means are provided for flexing a finger relative to the base region and snap releasing the flexed finger relative to the base region for imparting the energy pulse noted above. For example, lever


70


and cam


71


are used to flex the fingers wherein lever


70


is manually rotated rotating the cam


71


, forming a cam means, in the directions of the arrows in the sequence from

FIG. 5

to FIG.


7


. The cam


71


grips one set of aligned overlying fingers


102


and


112


of the disc assembly


98


that is aligned therewith and with the member


86


.




As the cam


71


rotates, it also rotates and bends the aligned fingers


102


and


112


, but not the ring


114


or its fingers, on the support


76


. The downward flexing of the disc assembly


98


by the cam


71


flexes the two fingers


102


and


112


downwardly. These fingers then flex downwardly the aligned ring


114


finger


118


and the member


86


, FIG.


5


.




The member


86


assists in optimizing the shearing action between the ring


114


and the fingers


102


and


112


.




This action bends the flat resilient member


86


and the aligned fingers accordingly relative to the support


76


as shown, FIG.


5


. In the alternative, the member


86


may be rigid. The disc


98


fingers are bent downwardly from the upper plane surface of the support


76


and the plane of disc


98


, causing the aligned fingers


102


and


112


to break their bonds with each other by a relative sliding shearing action and to break the bond between disc


112


and ring


114


by the relative shear sliding caused by the bending action. The pin


84


keeps the ring


118


periphery


116


secured to the support


76


as the cam


71


rotates.




In

FIG. 6

, as the fingers


102


and


112


continue to rotate in response to rotation of the cam


71


, the fingers


102


and


112


snap free of the bonds and slide over and past the fingers


118


of the ring


114


and the member


86


. The spacer disc


108


retains the selected dosage


104


in place on the corresponding finger


102


as the mating ring finger


118


slides over the spacer disc


108


. The resilient retention of the tips of the fingers


102


and


112


overlapping the member


86


and ring


114


finger creates a snap action of the fingers as the fingers rotate in response to further rotation of the cam


71


, FIG.


6


.




This snap action accelerates the substrate finger


102


with the dosage


104


against the bottom surface of the dispensing chamber


54


′ which serves as an anvil about opening


55


. This creates a large impact force and rapid deceleration of the selected dosage finger


102


. The momentum of the medicament during deceleration supplies energy to free the dosage from the surface


109


of the finger


102


upon the impact of the finger


102


with the anvil formed by the chamber


54


′ bottom surface. This momentum energy pulse causes the dosage medicament powder to be released from the disc


100


. The dosage is discharged at the mouthpiece


72


port


74


as a powder cloud through the discharge opening


55


. The valves


94


automatically open in response to an inhalation bolus and the concurrent air flow caused by the fan


68


. The user inhales the freed powder discharged from the mouthpiece. The air inlet port


92


permits the inhaled air to draw an airstream in the direction of the arrows at the inlet port


92


through the mouthpiece


72


.




The cam opening


58


,

FIG. 4

, permits the cam


71


to rotate while flexing the fingers


102


and


112


at the slot


56


. The particles readily release from the carrier substrate to provide the anticipated dosage.




In

FIG. 7

, manual rotation of the cam


70


in the reverse direction returns the fingers to the disc assembly


98


plane position. The aligned ring finger


118


acts as a resilient stop and positions the fingers


102


and


112


in the quiescent spent position below the fingers


118


of the ring


114


. The user may now index the next dosage for use in the next usage period at the support


76


.




In the alternative, the member


86


may be rigid and arcuate having the shape as shown in FIG.


5


. This arcuate shape assists in the relative shearing action of the fingers as they slide over the member


86


. In the alternative, the member


86


may be omitted.




Thus, drug removal results by a momentum transfer mechanism that disrupts the drug-substrate/carrier and particle to particle bonds. Enhanced drug release is provided for the particles.




In

FIGS. 8-10

, further means are shown for flexing the fingers relative to the base region form imparting an energy pulse to the dosage for releasing the dosage from the finger by momentum transfer. For example, in an alternative embodiment, inhaler apparatus


122


(the housing and drive mechanism not being shown), includes a drive means for displacing a belt portion to increment the fingers, for example, such as a drive gear and motor (not shown) for rotating a reel


124


of a preferably metal dosage carrier substrate


126


carrying a medicament dosage


128


and sealed with a sealing tape


130


. A sealing tape take-up reel


132


, also driven by a drive gear and the motor, removes the sealing tape


130


from the substrate


126


and dosage


128


as the substrate is removed from the reel


124


. A substrate take-up reel


134


, driven by a further drive gear and the motor (not shown), removes the substrate from the reel


124


. The reels may be part of a cartridge or cassette (the housing of which is not shown). The drive gears and circuitry for operating this system need not be shown because they are within the skill of those of ordinary skill.




In

FIG. 9

, the substrate


126


comprises a plurality of trapezoidal (or in the alternative triangular) fingers


136


and a continuous longitudinal extending belt


138


. The dosage


128


is deposited on the free ends of the carrier fingers


136


. The carrier substrate


126


preferably comprise metal leaf spring material. The fingers


136


extend transversely from the belt


138


.




A clamp and dosage removing assembly


140


receives the substrate


126


and a selected dosage


128


. The assembly


140


includes a clamp


141


for clamping the belt


138


next adjacent to the finger


136


′ in the assembly


140


. The clamp


141


may comprise a slotted structure for receiving the belt


138


and prevent the belt


138


in the clamp


141


from displacing in a direction normal to the substrate (and normal to the drawing paper in FIG.


9


).




The clamping assembly


140


includes an actuator


142


, FIG.


9


. The actuator includes a drive


143


which selectively rotates a pin


144


whose tip


144


′ underlies the tip of the finger


136


′ located within the clamp assembly


140


. The pin


144


may also underlie the dosage


128


′ on the finger


136


′. As the pin


144


is rotated,

FIG. 10

, it also rotates the finger


136


′ tip and the associated dosage


128


′. As the pin


144


rotates eventually it will release the finger


136


′ because they rotate in opposite directions


143


and


143


′ (The rotated finger and pin being shown in phantom). This relative rotation permits the finger


136


′ when released from the pin


144


to snap back to its quiescent position shown in solid line. This snapping action causes the dosage to be displaced from the substrate by momentum transfer. While the dosage


128


is shown on a side of the finger


136


opposite the pin


144


by way of illustration, they may be on the same side in the alternative.





FIG. 12

illustrates an alternative carrier substrate


131


which is formed of corrugated metal leaf spring with the corrugations running along the length of the fingers of the substrate such as the substrate


126


,

FIG. 9

, for example, or the fingers of the disc substrate


100


,

FIGS. 3 and 3



a


. The substrate is made stiffer by the corrugations without increasing the mass of the substrate. This increases the substrate acceleration for a corresponding smaller displacement of the finger. When the fingers


136


of

FIG. 8

, when corrugated, snap, they snap with increased acceleration over a shorter distance which further enhances the momentum energy transfer discharge of the dosage free of the substrate. The same occurs with the embodiment of

FIGS. 3 and 3



a.






In addition, in

FIG. 12

, further means for imparting an energy pulse may be provided. For example, a cylindrical hollow core preferably metal anvil


133


having a central opening


135


is positioned to receive the returning snapped finger acting as a stop for the finger in its normal quiescent position. The anvil


133


, for example, in

FIG. 1

, may be attached to housing half


62


″ over opening


55


. For example, the anvil


133


may be a molded integral portion of the housing half


62


″. The anvil


133


central opening


135


receives the released dosage from the substrate and disperses the particles into a cloud due to the momentum transfer forces. When the corrugated snapped finger substrate


131


impacts the anvil


133


,

FIG. 12

, the dosage is flung free to the substrate as a dispersed particle cloud


137


.




Means may be provided for creating an air jet stream through a channel to disintegrate aggregations. For example, the anvil


133


may have conduits


139


or channels interior to the opening


135


therethrough. When a person inhales, the breath bolus creates an air stream


146


through each of the conduits


139


which help break up agglomerates of the drug particles. This is particularly useful for large dosage deposits.




In

FIG. 11

, an alternative embodiment, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, employing a corrugate finger, includes a corrugated preferably metal stainless steel leaf spring finger


150


extending from a base region not shown, for example, on a disc dosage carrier substrate as described previously. An overlying second resilient spring finger


152


also extends from the base region. The finger


152


is flat with no openings therethrough. The finger


152


is of different material than finger


150


and has less resiliency than finger


150


,i.e., is not as stiff and, therefore, accelerates from a bent position at a slower rate than the finger


150


for a given deflection.




The finger


152


extends for the length of finger


150


and preferably overlies the entire finger


150


. A channel member


154


defines a channel region


156


which receives the fingers


150


and


152


in their normal quiescent position (not shown in this figure) and flexed configuration. This quiescent position is parallel to the member


154


bottom wall


158


at the bottom of the channel region


156


. Wall


158


has a through opening


159


to permit excess flow of air created by the finger


150


to exit the channel region when the flexed finger


150


returns to the flat state. This opening is then covered by the spring finger


150


when it returns to its quiescent position.




Also anvil


160


is located at the channel region bottom and secured to wall


158


. Anvil


160


may be similar to the anvil


133


as described above in connection with FIG.


12


.




An actuating pin


160


is rotated in direction


162


by a drive


164


. The pin


160


passes through a slot


165


in the channel member


154


rear wall


166


. The finger


152


has a spring constant different than that of the finger


150


. This different spring constant is such that finger


150


snaps back to its original quiescent position at a higher acceleration rate than finger


152


.




In operation, the pin


160


is selectively rotated in direction


162


. The tip of the pin


160


(or other shaped element) is beneath the spring fingers


150


and


152


, or in the alternative, beneath just finger


150


at its end tip region. As the pin is rotated upwardly in direction


162


the fingers


150


and


152


are flexed upwardly bending them about a pivot at which the fingers are secured to a base member (not shown).




The corrugated finger


150


is stiffer than finger


152


and accelerates at a higher rate, hitting the anvil


160


first. The slower moving finger


152


lags the finger


150


during the return motion to the quiescent state. The finger


152


acts as an air pump within the channel region


156


which closely receives the finger


152


and creates an air flow toward the anvil


160


. This air flow creates air streams through the apertures


160


′ in the anvil to break up aggregations of the powder dosage. This action insures that the dosage is in proper particle size format when inhaled maximizing its effectiveness. In

FIG. 11

it should be appreciated that the dosage is on the underside of the corrugated finger


150


and is not shown. The spring


150


causes its created air flow to flow through the opening


159


.




The corrugated springs may form stand alone components or joined together by or formed as a tape or formed into a pin wheel or disc for purposes of advancing dosages into an inhalation chamber. Once in the chamber, the deflected spring is released so that the drug is accelerated and leads the advancing spring end. At the peak velocity, the free end of the spring strikes the rigid anvil


160


and is rapidly decelerated. The impact with the anvil


160


and the rapid deceleration result in forces sufficiently high to release the individual and aggregate drug particles from the spring by momentum transfer forming a powder cloud. Aggregate particles are disrupted once they leave the substrate by the jets of gas through which the dislodged particles must pass. Due to rapid motion of the aggregates through the jets, a timed jet is provided that represents only a fraction of the inhaled bolus. This permits aggregate disruption without disruption to the patient's breathing pattern.




In a further embodiment, in the alternative, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example whereby corrugations in the region of the deposited dosage may be replaced with cupped shaped substrates, such as illustrated by fingers


102


′,

FIG. 3



b


, for example, provide the desired stiffness and flexibility in a manner similar to that of the corrugated substrate. This configuration provides additional stiffness without increasing the mass and results in more rapid deceleration and improved drug release. This provides the desired energy pulse to the substrate to release the drug rapidly.




In the alternative, means for creating an air jet stream may include a piston, not shown, which may receive the impact of the spring


152


to create an air flow through the anvil


160


apertures


160


′.




In

FIG. 13

, a corrugated substrate


150


′ has pockets


151


in each of which is disposed a medicament powder dosage


153


. A sealing tape


155


seals the dosages in the pockets


151


. The sealing tape must then be selectively removed prior to release of the dosage. The tape does not contact the dosage so as to not remove any of the dosage when the tape is removed.




It should be understood that the transfer of the dosages in the various embodiments is by imparting an energy pulse to the powder on the carrier substrate by deflecting the carrier substrate and the subsequent rapid deceleration of the substrate. Upon resilient return of the deflected substrate, it impacts a stationary anvil or its equivalent imparting a momentum or inertial energy pulse to the moving dosage. This energy pulse transfers the dosage by way of its momentum energy induced when its support substrate rapidly decelerates upon impact with a stationary object.




This is to be distinguished from impact transfer in the prior art attributed to shock energy imparted to a relatively stationary substrate. The impact shock waves travel through the substrate to the particles thereon, releasing the particles by a direct impact force on the stationary particles. This is different than momentum transfer in which the momentum inertial energy in the moving dosage is what separates the dosage from the rapidly decelerating carrier substrate. In contrast, shock waves impart motion to the otherwise stationary powder carried on the substrate. The shock waves incident on the powder impel the powder from the carrier substrate.




The separation mechanism forces are different in the two arrangements. One is an impelling force similar to a golf club hitting a stationary ball and the other is inertial wherein the moving object tends to remain in motion when its carrier suddenly ceases motion as in a catapult.




In

FIG. 14

, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example in a further embodiment of a cassette for a tape substrate is shown. The cassette


170


, dashed lines, contains three reels


172


,


174


and


176


. Reel


176


stores a coil


178


of a dosage carrier substrate


180


covered with a sealing tape


182


. Sealing tape


182


seals the medicament dosages


194


in blisters


195


,

FIG. 14



a


, formed in the substrate


180


. Reel


174


takes up the sealing tape


182


into a coil, removing it from the substrate


180


exposing the dosage


194


. Reel


172


takes up the substrate


180


after the dosages


194


are removed.




A hollow mouthpiece


184


for the inhaler (the remainder of which is not shown) is aligned with the dosage


194


to be dispensed. The mouthpiece


184


is adjacent to anvil


197


. The anvil


197


is a flat metal plate with an aperture


199


for passing the dosage


194


therethrough. The anvil


197


is next to the uncovered substrate


180


and dosage


194


to be dispensed, but spaced slightly therefrom. The inhaler includes a reel drive


186


for operating the reels


172


,


174


and


176


.




An impact mechanism


188


includes a cantilevered spring


190


driven by a spring deflection drive


192


. The drive


192


may be a rotating pin or element as discussed above in the embodiments of

FIG. 10

or


11


. A powder dosage


194


deposited by a deposition technique as disclosed, for example, in the aforementioned applications and patents in the introductory portion is on the carrier substrate


180


blister


195


at a dose release position


191


aligned with the spring


190


. The spring


190


has an aperture


193


for receiving and seating the blister


195


therein. The aperture


193


aligns the dosage


194


at the anvil aperture


199


.




Drive


192


deflects the spring


190


and carrier substrate which impacts the dosage carrying substrate


180


against the anvil


197


. The impacted substrate


180


imparts a momentum transfer motion to the dosage


194


. This action releases the dosage into a powder cloud upon impact of the substrate with the anvil. The cloud is inhaled by the user via the mouthpiece


184


.




In

FIG. 15

, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, embodied in a reel drive and deflection drive (not shown) as described in connection with

FIG. 14

is also employed. Most of the elements in

FIG. 15

are the same or similar to those in FIG.


14


. The difference is that the substrate


180


′ has a blister pocket


195


′,

FIG. 15



a


, for receiving a dosage


194


′ surrounded by an annular depression


189


. The sealing tape


187


has a score over each blister pocket


195


′. The anvil


177


is a flat plate with an annular outer depending ring rib


179


that mates in the depression


189


. The anvil has a central aperture


181


for receiving the dosage therethrough. As a result, the sealing tape rides directly on and over the anvil


177


and the dosage carrier substrates rides directly on and over the spring


190


′. The sealing tape


187


and substrate


180


′ are coiled and taken up in a take-up rewind reel


172


′. In

FIG. 14

, the reel


172


only takes up and coils the substrate


180


.




In operation, during an index cycle, the web of the carrier substrate, dosage and sealing tape is advanced. The blister pocket


195


′ is inserted into the leaf spring


190


′ aperture


193


′, loaded and fired against the anvil


177


. The anvil


177


outer ring rib


179


forces the cover sealing tape


187


to rupture along the score


185


,

FIG. 15



b


, and be pulled into the outer ring depression


189


of the dosage substrate exposing the powdered dosage


194


′. The spring


190


′ continues in its travel and the impact with the anvil


177


releases the dosage


194


′,

FIG. 15



b


, from the substrate


180


′.




In

FIG. 16

, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, is embodied in a cartridge


196


, which is employed with an inhaler (not shown). The cartridge comprises a central core


198


and a spiral array of cantilevered spring fingers


200


. Included is a core member drive means for selectively rotating the core about an axis to locate each finger at a given angular position about the axis. The fingers


200


extend radially outwardly from the core


198


and may be molded thermoplastic or metal. Each finger


200


includes a deposited medicament powder dosage


202


. The dosages are deposited in any known technique as discussed hereinabove. The dosages are sealed with a sealing tape


204


. The dosages may be deposited in a pocket in the finger dosage carrier substrate or the sealing tape may have performed pockets for receiving the dosage so there is no contact of the tape with the powdered dosage. The tape


204


is removed by reel


205


with a reel take-up drive (not shown) selectively exposing the dosages one at a time as they are to be dispensed.




By way of example, the fingers


200


may be supplied as a strip with the dosages thereon. The core


198


in this case has a spiral groove (not shown) in its side wall. The finger strip is then inserted in the spiral groove. The core


198


is rotatable about two spindles (not shown) at opposite axial ends of the core.




The take-up reel


205


removes the sealing tape


204


over the dosages


202


and fingers


200


as the dosages are rotated to a dispensing position


206


at a given angular position relative to the core


198


.




Means are at an angular position for displacing a finger along the axis, for example, a finger deflecting device


208


deflects the fingers


200


one at a time after the selected finger is rotated to the dispensing position


206


. Such as deflecting device may be as shown in

FIGS. 10 and 11

, for example. An apertured flat anvil


203


is fixed over and adjacent to the finger at position


206


. As the core is rotated, the spiral path of the fingers


200


containing a dosage to be dispensed displaces relatively downwardly in axial direction


210


at position


206


.




A guide


212


is connected to the finger deflecting device


208


represented by the dashed line


213


and slides in direction


210


in a channel in the inhaler housing (not shown). The guide axially positions the finger deflecting device as the selected dosage and finger relatively displace axially as the spiral is rotated. The guide


212


engages the spring fingers at a location spaced from the deflecting device and associated deflected finger. The guide


212


is positioned axially in direction


210


as the fingers are rotated about axis


214


. The guide


212


for example has a slot (not shown) which receives the edges of the fingers as the fingers are rotated about axis


214


. The fingers


200


hold the guide


212


in the axial position. An axial channel (not shown) in the housing holds the guide in its annular position


206


about the axis


214


.




In operation, a user rotates the core


198


to locate a dosage and its corresponding carrier finger to the desired axial and angular position relative to axis


214


at angular position


206


of the deflecting device


208


. The sealing tape


204


is peeled free of the dosage as the core is rotated by take up reel


205


. A detent device, e.g., a spring loaded ball attached to the housing (not shown) and a depression in the core


198


corresponding to each finger


200


angular position about axis


214


, may provide such a position for a manually rotatable core.




Manually operated finger


200


deflecting device


208


deflects the selected dosage carrier finger


200


at position


206


downwardly direction


210


. When the displaced finger


200


is released it snaps back against the anvil


203


carried by the device


208


, releasing the selected dosage


202


in a manner described previously by momentum transfer. The released powder cloud is inhaled via mouthpiece


218


.




The mouthpiece is schematically illustrated as having a vertical orientation along axis


214


. In practice, the mouthpiece may be horizontal transverse to the axis


214


. The mouthpiece may be coupled to a channel (not shown) in the housing interior side wall for flowing the released powder cloud to the mouthpiece at the edge of the spiral substrate fingers at position


206


.




A fan and/or additional air flow paths for providing an auxiliary air flow to assist in exhausting the powder cloud during inhalation may also be provided as in

FIG. 1

for this and the embodiments of

FIGS. 14 and 15

. The reel


205


is also coupled to the guide


212


for displacement therewith in the axial direction. A mouthpiece


211


receives the discharged powdered dosage.




In

FIG. 17

, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, is shown in an embodiment similar to that of

FIG. 16

employing a spiral dosage carrier substrate with resilient cantilevered fingers. In this embodiment all of the elements of

FIG. 16

are utilized except that the dosage


202


are encapsulated at each finger


200


′ by a discrete sealing cover sheet


215


. The sealing cover sheet preferably has a pocket for receiving the dosage. In this case the take-up reel


205


of

FIG. 16

is not utilized. In its place, a device (not shown) peels back the discrete cover sheet


215


′ next prior to the deposition position


206


′.




In

FIGS. 18 and 18



a


, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, is shown in a further embodiment of an inhaler dispenser


218


, which includes a housing (not shown) having a chamber for receiving a cartridge


200


. The cartridge


200


comprises a stack


222


of dosage packs


223


. Each pack


223


comprises a circular cylindrical (or other shapes) dosage wafer blister type substrate


224


. The substrates


224


each comprise a thermoplastic blister forming a pocket for the powdered dosage


228


. The substrates may be any conventional material, and preferably formed thermoplastic. The powdered medicament dosage


228


is deposited in the pocket of each substrate


224


by any known process as discussed above.




The cartridge


220


, which may be any convenient packaging for the packs is inserted into the inhaler chamber. During an index cycle, the lead pack


223


′ is separated from the cartridge and stack by a dispensing device (not shown) and placed on the cantilevered dosage carrier leaf spring


226


in a mating pocket


227


or aperture (not shown) in the spring


226


. A flat anvil


230


, for example metal or plastic, has a dosage receiving aperture


232


. A mouthpiece


234


is adjacent to the aperture


232


for receiving a powder cloud dosage.




An impact mechanism including a spring deflection drive (not shown) is at station


236


for deflecting the spring


226


and impacting the dosage


228


and substrate


224


against the anvil


230


to impart the desired energy pulse to release the dosage. The anvil


230


aperture


232


is smaller than the substrate so the dosage substrate will impact against the anvil when the spring is directed toward the anvil


230


.




The deflection drive (not shown) selectively rotates and snap releases the spring


226


. Drive


238


may be manual or electrically operated. The released spring


226


impacts the deflected substrate


224


′ against the anvil


230


on a side facing the spring


226


to release the dosage by momentum transfer. The released dosage passes through the anvil aperture


232


into the mouthpiece


234


. The relative orientations and positions are given by way of illustration and may differ from that shown in a given implementation. After the dosage is released, the empty pack


223


′ substrate


224


is displaced to a storage location (not shown) by a displacement device (not shown).




In

FIGS. 19 and 19



a


, means for flexing a finger, for snap releasing a finger and for imparting an energy pulse, for example, is shown in a further embodiment of a cartridge dispenser for stacked substrates which includes a cartridge


240


mounted in an inhaler chamber (not shown). Cartridge


240


is any convenient packaging for stacked substrates which comprises a stack


242


of separate substrate-dosage packs


241


. Each pack


241


comprises like discrete formed thermoplastic blister type substrates


243


each having a dosage


246


receiving pocket


244


. A medicament dosage


246


is in each pocket. The dosages


246


are sealed by a discrete sealing cover


248


over each substrate


242


forming the completed pack


241


.




A flat anvil


254


is adjacent to the mouthpiece


256


. The anvil


254


has a dosage receiving aperture


258


. The anvil is secured fixed to the inhaler housing (not shown) as in the prior embodiments discussed above herein.




Means are provided for selectively placing successive dosages and dosage substrates on a carrier such as during indexing, when the cover


248


is removed from the substrate


243


by a device (not shown). The exposed dosage


246


and substrate


243


of the pack


241


are then placed in a pocket


250


in dosage carrier spring


252


by a mechanism (not shown). Mouthpiece


256


is at the dosage dispensing station. The spring


252


and carried dosage are displaced by a deflection device (not shown) which deflects the spring to the position shown in the Figure with the substrate and dosage thereon. The displaced spring upon snap release by the deflection device, will impact the anvil


254


, and release the dosage


246


from the substrate


243


. The substrate


243


is smaller than the aperture


258


in the anvil so that the anvil restrains the substrate upon impact. This action provides momentum transfer energy to the dosage which forms a powder cloud that is dispensed through the mouthpiece


256


.




It will occur to one of ordinary skill that modifications may be made to the disclosed embodiments without departing from the scope of the invention as defined in the appended claims. The description given herein is by way of illustration and not limitation. For example, the shape of the fingers and the particular actuating mechanisms are by way of example. Numerous other actuating mechanisms may be provided for flexing a spring finger to impart an energy pulse to a dosage on a substrate to transfer the dosage by momentum transfer forces.



Claims
  • 1. A medicament powder delivery device comprising:a carrier having at least a flexible portion including a dosage carrier finger resiliently extending from a base region on which finger is a discrete medicament dosage; and means for flexing the finger relative to the base region and snap releasing the flexed finger relative to the base region for imparting an energy pulse to the dosage for releasing the dosage from the finger by momentum transfer.
  • 2. The device of claim 1 including a body with a cavity for receiving the flexible portion and the means for imparting, the device including an anvil with a bore therethrough fixed to the body in the cavity for impact receiving the snap released finger, the bore for receiving said released dosage, and including means for causing said finger to resiliently impact said anvil to rapidly decelerate the finger to provide said momentum transfer to the dosage.
  • 3. The device of claim 2 wherein said anvil including at least one channel, further including means for creating an air jet stream through said at least one channel to disintegrate aggregations of said dosage during said impact.
  • 4. The device of claim 1 wherein the finger is corrugated.
  • 5. The device of claim 3 wherein the carrier finger extends in a given direction from the base region, the finger having corrugations extending along said direction.
  • 6. The device of claim 3 wherein the means for creating said jet stream includes a further resilient finger overlying the carrier finger for initial resilient displacement coincident with initial displacement of the carrier finger, said displaced fingers for snap release in a second displacement, said further finger for creating said air jet stream during said second displacement.
  • 7. The device of claim 6 wherein the further finger has a different relaxation time than the carrier finger so as to accelerate slower than the carrier finger upon said snap release.
  • 8. The device of claim 1 wherein the carrier includes a first disc with a plurality of radially extending fingers, a dosage on each finger, and the means for imparting comprises cam means for snap flexing a selected finger to release the dosage on the selected finger.
  • 9. The device of claim 8 including index means for indexing the selected finger to a medicament release position for snap flexing the selected finger by said cam means.
  • 10. The device of claim 9 wherein the first disc includes a dosage carrier disc with a plurality of first fingers each carrying a dosage, a spacer disc overlying the carrier disc with a plurality of second fingers overlying and corresponding to the first fingers and a ring with index holes and a third plurality of fingers over lying and corresponding to the first and second fingers, said spacer disc being bonded to the carrier disc and ring, said indexing means for selectively engaging said ring index holes.
  • 11. The device of claim 10 wherein the cam means flexes the first and second fingers past the third fingers.
  • 12. The device of claim 1 wherein the carrier comprises a belt portion with a plurality of said fingers extending transversely from the belt portion, each said fingers having a separate dosage and arranged for selective resilient displacement relative to said belt portion.
  • 13. The device of claim 12 further including drive means for displacing said belt portion to increment said fingers sequentially to a dosage release position.
  • 14. The device of claim 12 wherein the means for imparting includes a clamp for clamping the belt portion adjacent to a given finger and a deflecting member for selectively flexing and snap releasing the selected given flexed finger relative to the belt portion.
  • 15. The device of claim 1 wherein said finger is for receiving a dosage and dosage substrate from a plurality of dosages and dosage substrates in a stack aligned one over another, further including means for selectively placing successive dosages and dosage substrates on said carrier, said means for imparting including means for snap deflecting said finger against an anvil.
  • 16. The device of claim 1 wherein the carrier comprises an element having a plurality of said fingers, said dosage comprising a dosage on each finger, said means for flexing including a finger deflection member adjacent to said element for momentarily bending and deflecting a selected finger to momentum transfer release a selected dosage from the finger upon release of the deflected finger.
  • 17. The device of claim 16 including means for selectively aligning successive dosages on said element to said deflection member.
  • 18. The device of claim 16 including a core member rotatable about an axis, said element comprising an array of said fingers radially extending from the core member about the core member in a spiral about said axis, said device including means for selectively aligning and deflecting each said finger to snap release a selected dosage from the selected finger by said momentum transfer.
  • 19. The device of claim 1 further including:a cartridge containing said carrier, said carrier comprising a plurality of said fingers; the medicament dosage comprising a dry powder in a discrete location on each finger; a housing for receiving the cartridge; and the means for flexing for momentarily deflecting a selected finger to accelerate and rapidly decelerate the selected finger for said imparting; the cartridge comprising a cylindrical core member, said plurality of fingers extending radially from the cylindrical core member in a spiral array, said means for flexing including anvil means for said rapid deceleration of the selected flexed finger.
  • 20. The device of claim 19 wherein the means for selectively deflecting includes a core member drive means for selectively rotating the core member about an axis to locate each finger at a given angular and axial position about the axis and a finger deflecting device at said given position, said selectively deflecting means including means at said angular position for displacing the finger along said axis.
  • 21. A dry powder deliver device comprising:a cartridge containing at least one dosage carrier substrate; a dry powder in an array of discrete locations on the at least one substrate; a housing for receiving the cartridge; and means for momentarily deflecting the carrier substrate to accelerate and rapidly decelerate the substrate to momentum transfer and discharge the powder from the substrate at a selected location; the cartridge comprises a plurality of reels with the carrier substrate suspended between the reels, the means for deflecting comprising a cantilevered spring member for said momentarily deflecting the carrier substrate between said reels and a fixed anvil for impact receiving the deflected substrate.
  • 22. A dry powder delivery device comprising:a cartridge containing at least one dosage carrier substrate; a dry powder in an array of discrete locations on the at least one substrate; a housing for receiving the cartridge; and means for momentarily deflecting the carrier substrate to accelerate and rapidly decelerate the substrate to momentum transfer and discharge the powder from the substrate at a selected location; the cartridge comprising a disc having a plurality of radially outwardly extending fingers, each finger having a dosage thereon and the means for deflecting including means for selectively deflecting each said finger.
  • 23. A dry powder delivery device comprising:a cartridge containing at least one dosage carrier substrate; a dry powder in an array of discrete locations on the at least one substrate; a housing for receiving the cartridge; and means for momentarily deflecting the carrier substrate to accelerate and rapidly decelerate the substrate to momentum transfer and discharge the powder from the substrate at a selected location; the cartridge comprising a stack of medicament dosages each on a discrete substrate, a spring for receiving a selected dosage on a substrate from the stack, said means for deflecting for selectively deflecting each substrate in a sequence.
  • 24. A dry powder delivery device comprising:a cartridge containing at least one dosage carrier substrate; a dry powder in an array of discrete locations on the at least one substrate; a housing for receiving the cartridge; and means for momentarily deflecting the carrier substrate to accelerate and rapidly decelerate the substrate to momentum transfer and discharge the powder from the substrate at a selected location; the cartridge comprising a member having a base and a linear array of fingers extending from the base, each finger being flexible relative to the base and including a medicament powder dosage, said means for deflecting for selectively deflecting each finger in a sequence.
  • 25. The device of claim 24 wherein the fingers are rectangular and parallel.
  • 26. The device of claim 24 wherein the fingers are triangular and parallel.
  • 27. The device of claim 24 wherein the at least one substrate has a plurality of depressions each containing a separate powder dosage and a sealing tape bonded to the substrate over the depressions and spaced from the dosages.
Parent Case Info

Of interest are co-pending application Ser. No. 08/661,213 (PCT/US97/10162) entitled Inhaler Apparatus with Modified Surfaces for Enhanced Release of Dry Powders filed Jun. 10, 1996 in the name of Datta et al., Inhaler Apparatus with an Electronic Means for Enhanced Release of Dry Powders Ser. No. 08/661,212 filed Jun. 10, 1996 in the name of Sun et al. (PCT/US97/10162), Ser. No. 08/932,489 (PCT/US98/19228) entitled Dry Powder Delivery System filed Sep. 18, 1997 in the name of Leedom et al., Ser. No. 08/467,647 entitled Apparatus for Electrostatically Depositing and Retaining Materials Upon a Substrate filed Jun. 6, 1995 now U.S. Pat. No 5,669,973, Ser. No. 08/506,703 entitled Inhaler Apparatus for Using a Tribo-Electric Charging Technique filed Jul. 25, 1995 now U.S. Pat. No. 5,642,727, Ser. No. 08/659,501 entitled Methods and Apparatus for Electrostatically Depositing a Medicament Powder Upon Predefined Regions of a Substrate filed Jun. 6, 1996 in the name of Pletcher et al. now U.S. Pat. No. 6,007,630, Ser. No. 09/095,246 entitled Dry Powder Deposition Process filed Jun. 10, 1998 in the name of Poliniak et al. now U.S. Pat. No. 6,063,194, all of the foregoing being commonly owned; and Ser. No. 09/095,616 entitled Pharmaceutical Product and Method of Making filed Jun. 10, 1998 in the name of Chrai et al. now U.S. Pat. No. 6,303,143, the latter application being commonly owned with the assignee of the aforementioned foregoing applications and with the assignee of the present invention, and U.S. Pat. Nos. 5,714,007, 5,642,727, 5,669,973 commonly owned with the aforementioned foregoing applications. All of the aforementioned are incorporated by reference herein in their entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US99/02869 WO 00
Publishing Document Publishing Date Country Kind
WO99/44663 9/10/1999 WO A
US Referenced Citations (7)
Number Name Date Kind
4203454 Wutscher May 1980 A
5437271 Hodson et al. Aug 1995 A
5469843 Hodson Nov 1995 A
5619984 Hodson et al. Apr 1997 A
5655523 Hodson et al. Aug 1997 A
5740793 Hodson et al. Apr 1998 A
6029663 Eisele et al. Feb 2000 A
Foreign Referenced Citations (3)
Number Date Country
WO9013328 Nov 1990 WO
WO9309832 May 1993 WO
WO9725086 Jul 1997 WO